ProShares Ultra NASDAQ Biotechnology
BIB
BIB
7 hedge funds and large institutions have $2.52M invested in ProShares Ultra NASDAQ Biotechnology in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
7
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$678K | |
| 2 | +$464K | |
| 3 | +$28.8K | |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$25.9K |
| 5 |
AIG
American International Group
New York
|
+$12.9K |
Top Sellers
| 1 | -$805K | |
| 2 | -$50.2K | |
| 3 | -$23K | |
| 4 |
CA
CapWealth Advisors
Franklin,
Tennessee
|
-$1K |